Rv0129c: fbpCRv0340Rv0341: iniBRv0342: iniARv0343: iniCRv1483: mabARv1484: inhARv1854c: ndhRv1592cRv1772Rv1908c: katG1909c: furARv2242: srm R homologRv2243: fabDRv2245: kasARv2247: accD6Rv2427A: oxyRRv2428: ahpCRv2846c: efpARv3139: fadE24Rv3566c: nhoARv3795: embB

Rv1908c

More about Rv1908c on    TBDB.org

More about Rv1908c on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv1908c: Codons 260 to 279: 7 mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Rouse DA AAC 1995 ACA/AGA 785 262 Thr/Arg 1995 USA, South Korea PCR-SSCP, Sequencing Whole gene H 1 ug/ml Absolute concentration method 26/26 1/0 - -
Cockerill FR JID 1995 GCG/ACG 790 264 Ala/Thr 1995 USA, Japan Sequencing Whole gene - "0.25; catalase 14mm" "Middlebrook 7H11 agar; 1% Proportion method" - 1/0 Pro2Ser, Ala65Thr, Ala66Pro, Met126Ile, Ala243Ser, Asn258Ser, Tyr337Phe -
Chan RCY JAC 2007 del G - 268 Frameshift 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Pretorius GS AAC 1995 ACC/GCC 820 275 Thr/Ala 1995 South Africa, Switzerland PCR-SSCP, Sequencing Whole gene? HR,HRSEEryB 10 & >2.5 ug/ml Agar dilution method 39/69 2/0 - -
Heym B MolMicro 1995 ACC/CCC 823 275 Thr/Pro 1995 France PCR-SSCP, Sequencing Whole gene HMDR > 10 ug/ml Proportion method 34/37 1/0 - -
Ramaswamy SV J Med Micro 2004 ACC/TCC 823 275 Thr/Ser 1996-1998 Mexico Directed Oligonucleotide array, Sequencing codon 228-357 HR >=1% growth 0.2ug/ml I, 40ug/ml R, 4ug/ml S, 2ug/ml E Proportion method 37/50 1/0 His445Asp rpoB, -
Morlock GP AAC 2003 GGC/GAC 836 279 Gly/Asp 2003 Brazil Sequencing fragment encompassing codons 249 to 342 HEth >32 I, >200 Eth Microplate alamar blue assay 17/41 1/0 D55/A ethA,L44L inhA ORF, C(-15)T inhA regulator

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator